Mateos, Maria Victoria; Weisel, Katja; Terpos, Evangelos; Delimpasi, Sossana; Kastritis, Efstathios; Zamagni, Elena; Delforge, Michel; Ocio, Enrique; Katodritou, Eirini; Gay, Francesca; Larocca, Alessandra; Leleu, Xavier; Otero, Paula Rodriguez; Schjesvold, Fredik; Cavo, Michele; Dimopoulos, Meletios A., Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma, «HAEMATOLOGICA», 2024, 0, pp. 0 - 0 [Scientific article]
Vigliotta, Ilaria; Solli, Vincenza; Armuzzi, Silvia; Martello, Marina; Poletti, Andrea; Taurisano, Barbara; Pistis, Ignazia; Mazzocchetti, Gaia; Borsi, Enrica; Pantani, Lucia; Marzocchi, Giulia; Testoni, Nicoletta; Zamagni, Elena; Terracciano, Mario; Tononi, Paola; Garonzi, Marianna; Ferrarini, Alberto; Manaresi, Nicolò; Cavo, Michele; Terragna, Carolina, Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients, «CANCERS», 2024, 16, Article number: 2929 , pp. 1 - 22 [Scientific article]
Gentile M.; Vigna E.; Palmieri S.; Galli M.; Derudas D.; Mina R.; Pepa R.D.; Zambello R.; Martino E.A.; Bruzzese A.; Mangiacavalli S.; Zamagni E.; Califano C.; Musso M.; Conticello C.; Cerchione C.; Mele G.; Renzo N.D.; Offidani M.; Tarantini G.; Casaluci G.M.; Rago A.; Ria R.; Uccello G.; Barilà G.; Palumbo G.; Pompa A.; Vincelli D.; Brunori M.; Accardi F.; Amico V.; Amendola A.; Fontana R.; Bongarzoni V.; Rossini B.; Cotzia E.; Gozzetti A.; Rizzi R.; Sgherza N.; Ferretti E.; Bertuglia G.; Nappi D.; Petrucci M.T.; Raimondo F.D.; Neri A.; Morabito F.; Musto P., Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials, «HAEMATOLOGICA», 2024, 109, pp. 245 - 255 [Scientific article]Open Access
Bigi F.; Manzato E.; Barbato S.; Talarico M.; Puppi M.; Masci S.; Sacchetti I.; Restuccia R.; Iezza M.; Rizzello I.; Sartor C.; Mancuso K.; Pantani L.; Tacchetti P.; Cavo M.; Zamagni E., Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review, «PHARMACEUTICALS», 2024, 17, Article number: 944 , pp. 7 - 7 [Scientific article]Open Access
Rodriguez-Otero, Paula; Usmani, Saad; Cohen, Adam D; van de Donk, Niels W C J; Leleu, Xavier; Pérez-Larraya, Jaime Gállego; Manier, Salomon; Nooka, Ajay K; Mateos, Maria Victoria; Einsele, Hermann; Minnema, Monique; Cavo, Michele; Derman, Benjamin A; Puig, Noemi; Gay, Francesca; Ho, P Joy; Chng, Wee-Joo; Kastritis, Efstathios; Gahrton, Gösta; Weisel, Katja; Nagarajan, Chandramouli; Schjesvold, Fredik; Mikhael, Joseph; Costa, Luciano; Raje, Noopur S; Zamagni, Elena; Hájek, Roman; Weinhold, Niels; Yong, Kwee; Ye, Jing Christine; Sidhana, Surbhi; Merlini, Giampaolo; Martin, Tom; Lin, Yi; Chari, Ajai; Popat, Rakesh; Kaufman, Jonathan L, International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma, «THE LANCET ONCOLOGY», 2024, 25, pp. 0 - 0 [Scientific article]
Facon, Thierry; Dimopoulos, Meletios-Athanasios; Leleu, Xavier P.; Beksac, Meral; Pour, Ludek; Hájek, Roman; Liu, Zhuogang; Minarik, Jiri; Moreau, Philippe; Romejko-Jarosinska, Joanna; Spicka, Ivan; Vorobyev, Vladimir I.; Besemer, Britta; Ishida, Tadao; Janowski, Wojciech; Kalayoglu-Besisik, Sevgi; Parmar, Gurdeep; Robak, Pawel; Zamagni, Elena; Goldschmidt, Hartmut; Martin, Thomas G.; Manier, Salomon; Mohty, Mohamad; Oprea, Corina; Brégeault, Marie-France; Macé, Sandrine; Berthou, Christelle; Bregman, David; Klippel, Zandra; Orlowski, Robert Z., Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2024, 3, pp. 0 - 0 [Scientific article]
Terragna C.; Poletti A.; Solli V.; Martello M.; Zamagni E.; Pantani L.; Borsi E.; Vigliotta I.; Mazzocchetti G.; Armuzzi S.; Taurisano B.; Testoni N.; Marzocchi G.; Kanapari A.; Pistis I.; Tacchetti P.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M., Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features, «NATURE COMMUNICATIONS», 2024, 15, Article number: 1551 , pp. 1 - 18 [Scientific article]Open Access
Charliński G.; Steinhardt M.; Rasche L.; Gonzalez-Calle V.; Peña C.; Parmar H.; Wiśniewska-Piąty K.; Dávila Valls J.; Olszewska-Szopa M.; Usnarska-Zubkiewicz L.; Gozzetti A.; Ciofini S.; Gentile M.; Zamagni E.; Kurlapski M.; Legieć W.; Vesole D.H.; Jurczyszyn A., Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis, «CANCERS», 2024, 16, Article number: 1592 , pp. 1 - 17 [Scientific article]Open Access
Ielo, Claudia; Fazio, Francesca; Rocchi, Serena; Rizzello, Ilaria; Mancuso, Katia; Zamagni, Elena; Cavo, Michele; Petrucci, Maria Teresa, Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight, «LEUKEMIA RESEARCH REPORTS», 2024, 21, Article number: 100399 , pp. 1 - 4 [Scientific article]Open Access
Borsi, Enrica; Vigliotta, Ilaria; Poletti, Andrea; Mazzocchetti, Gaia; Solli, Vincenza; Zazzeroni, Luca; Martello, Marina; Armuzzi, Silvia; Taurisano, Barbara; Kanapari, Ajsi; Pistis, Ignazia; Zamagni, Elena; Pantani, Lucia; Rocchi, Serena; Mancuso, Katia; Tacchetti, Paola; Rizzello, Ilaria; Rizzi, Simonetta; Dan, Elisa; Sinigaglia, Barbara; Cavo, Michele; Terragna, Carolina, Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients, «CELLS», 2024, 13, pp. 657 - 675 [Scientific article]Open Access
Autore, Francesco; Bramanti, Stefania; Lessi, Federica; Innocenti, Idanna; Galli, Eugenio; Rocchi, Serena; Ribolla, Rossella; Derudas, Daniele; Oliva, Stefania; Stefanoni, Paola; Marcatti, Magda; Schenone, Angelo; La Nasa, Giorgio; Crippa, Claudia; Zamagni, Elena; Riva, Marcello; Mazza, Rita; Mannina, Daniele; Sica, Simona; Bacigalupo, Andrea; Laurenti, Luca, Which is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome?, «HAEMATOLOGICA», 2024, 109, pp. 888 - 894 [Scientific article]Open Access
Mina R.; Musto P.; Rota-Scalabrini D.; Paris L.; Gamberi B.; Palmas A.; Aquino S.; de Fabritiis P.; Giuliani N.; De Rosa L.; Gozzetti A.; Cellini C.; Bertamini L.; Capra A.; Oddolo D.; Vincelli I.D.; Ronconi S.; Pavone V.; Pescosta N.; Cea M.; Fioritoni F.; Ballanti S.; Grasso M.; Zamagni E.; Belotti A.; Boccadoro M.; Gay F., Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial, «THE LANCET ONCOLOGY», 2023, 24, pp. 64 - 76 [Scientific article]
Raab, Marc S.; Zamagni, Elena; Manier, Salomon; Rodriguez‐Otero, Paula; Schjesvold, Fredrik; Broijl, Annemiek, Difficult‐to‐treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results, «EJHAEM», 2023, 4, pp. 1117 - 1131 [Scientific article]Open Access
Nanni, Cristina; Kobe, Carsten; Baeßler, Bettina; Baues, Christian; Boellaard, Ronald; Borchmann, Peter; Buck, Andreas; Buvat, Irène; Chapuy, Björn; Cheson, Bruce D; Chrzan, Robert; Cottereau, Ann-Segolene; Dührsen, Ulrich; Eikenes, Live; Hutchings, Martin; Jurczak, Wojciech; Kraeber-Bodéré, Françoise; Lopci, Egesta; Luminari, Stefano; MacLennan, Steven; Mikhaeel, N George; Nijland, Marcel; Rodríguez-Otero, Paula; Treglia, Giorgio; Withofs, Nadia; Zamagni, Elena; Zinzani, Pier Luigi; Zijlstra, Josée M; Herrmann, Ken; Kunikowska, Jolanta, European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours, «THE LANCET. HAEMATOLOGY», 2023, 10, pp. 367 - 381 [Scientific article]
Borsi E.; Mazzocchetti G.; Dico A.F.; Vigliotta I.; Martello M.; Poletti A.; Solli V.; Armuzzi S.; Taurisano B.; Kanapari A.; Pistis I.; Zamagni E.; Tacchetti P.; Pantani L.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M.; Terragna C., High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients, «CLINICAL AND EXPERIMENTAL MEDICINE», 2023, 23, pp. 5227 - 5239 [Scientific article]Open Access
